NAMS 2021 Utian Translational Science SymposiumSeptember 2021, Washington, DCCharting the path to health in midlife and beyond: the biology and practice of wellness.

Publisher: Lippincott-Raven Publishers Country of Publication: United States NLM ID: 9433353 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-0374 (Electronic) Linking ISSN: 10723714 NLM ISO Abbreviation: Menopause Subsets: MEDLINE

Publication: Hagerstown, MD : Lippincott-Raven Publishers
Original Publication: New York, NY : Raven Press, c1994-

Mental Health* ; Translational Science, Biomedical*; Biology ; Humans ; Washington

Abstract: Charting the Path to Health in Midlife and Beyond: The Biology and Practice of Wellness was a Translational Science Symposium held on Tuesday, September 21, 2021. Foundational psychosocial and behavioral approaches to promote healthy aging and strategies to disseminate this information were discussed. The following synopsis documents the conversation, describes the state of the science, and outlines a path forward for clinical practice. Wellness, in its broadest sense, prioritizes an orientation toward health, and an embrace of behaviors that will promote it. It involves a journey to improve and maintain physical and mental health and overall well-being to fully engage and live one's best life. It is more about recognizing and optimizing what one can do than what one cannot do and emphasizes the individual's agency over changing what they are able to change. Wellness is therefore not a passive state but rather an active goal to be sought continually. When viewed in this fashion, wellness is accessible to all. The conference addressed multiple aspects of wellness and embraced this philosophy throughout.
Competing Interests: Financial disclosures/conflicts of interest: N.F.S. reports receiving advisory fees from Astellas and Que-Oncology, research support from Menogenix, Inc (paid to the University of Colorado), and consultant fees from Ansh Labs. H.J. reports receiving grant support Merck, Pfizer, Que-Oncology, and NeRRe/KaNDy and consultant and advisory fees from Eisai, Jazz, and Bayer. H.J. also reports her spouse is an employee of Arsenal Biosciences and has an equity stake in Merck Research Labs and Tango Therapeutics.
(Copyright © 2022 by The North American Menopause Society.)

Swarbrick M. A wellness approach. Psychiatr Rehabil J 2006; 29:311–314.
Barzilai N, Atzmon G, Derby CA, Bauman JM, Lipton RB. A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology 2006; 67:2170–2175.
Hernandez-Vicente A, Hernando D, Santos-Lozano A, et al. Heart rate variability and exceptional longevity. Front Physiol 2020; 11:566399.
Kavanagh K, Espeland MA, Sutton-Tyrrell K, Barinas-Mitchell E, El Khoudary SR, Wildman RP. Liver fat and SHBG affect insulin resistance in midlife women: the Study of Women's Health Across the Nation (SWAN). Obesity (Silver Spring) 2013; 21:1031–1038.
Rodriquez EJ, Kim EN, Sumner AE, Napoles AM, Perez-Stable EJ. Allostatic load: importance, markers, and score determination in minority and disparity populations. J Urban Health 2019; 96: (suppl 1): 3–11.
Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci 2015; 10:227–237.
Holt-Lunstad J, Robles TF, Sbarra DA. Advancing social connection as a public health priority in the United States. Am Psychol 2017; 72:517–530.
Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med 2010; 7:e1000316.
Aging NIo. Available at: https://order.nia.nih.gov/publication/get-fit-for-life-exercise-physical-activity-for-healthy-aging . Accessed August 10, 2021.
Brown HL, Warner JJ, Gianos E, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation 2018; 137:e843–e852.
El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation 2020; 142:e506–e532.
Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2015; 100:3975–4011.
Medicine NAo. Healthy Longevity: Global Grand Challenge. Available at: https://nam.edu/initiatives/grand-challenge-healthy-longevity/ . Published 2020. Accessed April 25, 2022.
Kuller LH, Simkin-Silverman LR, Wing RR, Meilahn EN, Ives DG. Women's Healthy Lifestyle Project: a randomized clinical trial: results at 54 months. Circulation 2001; 103:32–37.
Li Y, Pan A, Wang DD, et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation 2018; 138:345–355.
Barone Gibbs B, Hivert MF, Jerome GJ, et al. Physical activity as a critical component of first-line treatment for elevated blood pressure or cholesterol: who, what, and how?: a scientific statement from the American Heart Association. Hypertension 2021; 78:e26–e37.
In: Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines . Geneva 2019.
Lourida I, Hannon E, Littlejohns TJ, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA 2019; 322:430–437.
Townsend LK, MacPherson REK, Wright DC. New horizon: exercise and a focus on tissue-brain crosstalk. J Clin Endocrinol Metab 2021; 106:2147–2163.
Mehta LS, Watson KE, Barac A, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 2018; 137:e30–e66.
Chlebowski RT, Luo J, Anderson GL, et al. Weight loss and breast cancer incidence in postmenopausal women. Cancer 2019; 125:205–212.
Chlebowski RT, Anderson GL, Manson JE, et al. Low-fat dietary pattern and cancer mortality in the Women's Health Initiative (WHI) randomized controlled trial. JNCI Cancer Spectr 2018; 2:ky065.
Chlebowski RT, Aragaki AK, Anderson GL, et al. Dietary modification and breast cancer mortality: long-term follow-up of the Women's Health Initiative Randomized Trial. J Clin Oncol 2020; 38:1419–1428.
Arthur R, Brasky TM, Crane TE, et al. Associations of a healthy lifestyle index with the risks of endometrial and ovarian cancer among women in the Women's Health Initiative Study. Am J Epidemiol 2019; 188:261–273.
Luo J, Hendryx M, Manson JE, et al. Intentional weight loss and obesity-related cancer risk. JNCI Cancer Spectr 2019; 3:kz054.
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140:e563–e595.
Reynolds G. Taking Up Running After 50? It's Never Too Late to Shine. Available at: https://www.nytimes.com/2019/09/18/well/move/takingup-rnning-after-50-its-never-too-late-to-shine.html . Published 2019. Accessed February 29, 2020.
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321–333.
Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133:933–941.
Zimmerman MA, Budish RA, Kashyap S, Lindsey SH. GPER-novel membrane oestrogen receptor. Clin Sci (Lond) 2016; 130:1005–1016.
Ogola BO, Clark GL, Abshire CM, et al. Sex and the G protein-coupled estrogen receptor impact vascular stiffness. Hypertension 2021; 78:e1–e14.
Groban L, Tran QK, Ferrario CM, et al. Female heart health: is GPER the missing link? Front Endocrinol (Lausanne) 2019; 10:919.
Centers for disease C, prevention. Adverse childhood experiences reported by adults—five states, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:1609–1613.
Epperson CN, Sammel MD, Bale TL, et al. Adverse childhood experiences and risk for first-episode major depression during the menopause transition. J Clin Psychiatry 2017; 78:e298–e307.
Shanmugan S, Cao W, Satterthwaite TD, et al. Impact of childhood adversity on network reconfiguration dynamics during working memory in hypogonadal women. Psychoneuroendocrinology 2020; 119:104710.
Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 1998; 14:245–258.
Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 2006; 96:1226–1235.
Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015; 175:531–539.
Kravitz HM, Kazlauskaite R, Joffe H. Sleep, health, and metabolism in midlife women and menopause: food for thought. Obstet Gynecol Clin North Am 2018; 45:679–694.
Freeman D, Sheaves B, Waite F, Harvey AG, Harrison PJ. Sleep disturbance and psychiatric disorders. Lancet Psychiatry 2020; 7:628–637.
Thurston RC. Vasomotor symptoms: natural history, physiology, and links with cardiovascular health. Climacteric 2018; 21:96–100.
Green SM, Donegan E, Frey BN, et al. Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial. Menopause 2019; 26:972–980.
Elkins GR, Fisher WI, Johnson AK, Carpenter JS, Keith TZ. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause 2013; 20:291–298.
Carmody JF, Crawford S, Salmoirago-Blotcher E, Leung K, Churchill L, Olendzki N. Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause 2011; 18:611–620.
Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 2009; 13:205–214.
Buysse DJ. Insomnia. JAMA 2013; 309:706–716.
Bromberger JT, Kravitz HM. Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN) over 10 years. Obstet Gynecol Clin North Am 2011; 38:609–625.
Duggan A, Street RL. Glanz K, Rimer BK, Viswanath K. Interpersonal communication in health and illness. Jossey-Bass, Health Behavior: Theory, Reserach and Practice . San Francisco, CA:2015.
Hall K. Understanding validation: a way to communicate acceptance. Psychology Today 2012. Available at: https://www.psychologytoday.com/us/blog/pieces-mind/201204/understanding-validation-way-communicate-acceptance . Accessed April 25, 2022.
Edmond SN, Keefe FJ. Validating pain communication: current state of the science. Pain 2015; 156:215–219.
Coslov N, Richardson MK, Woods NF. Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey. Menopause 2021; 28:1012–1025.
Prevention CfDCa. Available at: https://www.healthypeople.gov/2020/topics-objectives/topic/physical-activity . Accessed November 20, 2021.
Lee SH, Im EO. Ethnic differences in exercise and leisure time physical activity among midlife women. J Adv Nurs 2010; 66:814–827.
Im EO, Ko Y, Hwang H, et al. Racial/ethnic differences in midlife women's attitudes toward physical activity. J Midwifery Womens Health 2013; 58:440–450.
Kriska AM, Rockette-Wagner B, Edelstein SL, et al. The impact of physical activity on the prevention of type 2 diabetes: evidence and lessons learned from the diabetes prevention program, a long-standing clinical trial incorporating subjective and objective activity measures. Diabetes Care 2021; 44:43–49.
Prevention CfDCa. Adult Obesity Facts. Available at: https://www.cdc.gov/obesity/data/adult.html . Accessed November 23, 2021.
UAMS. What is Culinary Medicine? Available at: https://culinarymedicine.uams.edu/about-us/what-is-culinary-medicine/ . Accessed November 23, 2021.
Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368:1279–1290.
Marlatt KL, Pitynski-Miller DR, Gavin KM, et al. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring) 2022; 30:14–27.
Pontzer H, Yamada Y, Sagayama H, et al. Daily energy expenditure through the human life course. Science 2021; 373:808–812.
Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 2008; 32:949–958.
Marlatt KL, Pitynski-Miller DR, Gavin KM, Moreau KL, Melanson EL, Santoro N. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring) 2022; 30:14–27.
Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45:633–638.
Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011; 34:1481–1486.
Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep 2017; 6:187–194.
Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Church TS. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis 2014; 56:441–447.
Simkin-Silverman LR, Wing RR, Boraz MA, Kuller LH. Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial. Ann Behav Med 2003; 26:212–220.
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2014; 63 (25 pt B):2985–3023.
Saxon DR, Iwamoto SJ, Mettenbrink CJ, et al. Antiobesity medication use in 2.2 million adults across eight large health care organizations: 2009-2015. Obesity (Silver Spring) 2019; 27:1975–1981.
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021; 384:989.
Diabetes prevention program research g. long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care 2012; 35:.
Seppala EM, Nitschke JB, Tudorascu DL, et al. Breathing-based meditation decreases posttraumatic stress disorder symptoms in U.S. military veterans: a randomized controlled longitudinal study. J Trauma Stress 2014; 27:397–405.
Sharma A, Barrett MS, Cucchiara AJ, Gooneratne NS, Thase ME. A breathing-based meditation intervention for patients with major depressive disorder following inadequate response to antidepressants: a randomized pilot study. J Clin Psychiatry 2017; 78:e59–e63.

K01 DK128227 United States DK NIDDK NIH HHS; K12 AR084226 United States AR NIAMS NIH HHS; L30 AG069286 United States AG NIA NIH HHS; R13 AG069384 United States AG NIA NIH HHS

Date Created: 20220429 Date Completed: 20220503 Latest Revision: 20240216

20240216

PMC9248978

10.1097/GME.0000000000001995

35486944